CRIS Current Research Information System

RINALDI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.054
EU - Europa 941
AS - Asia 149
AF - Africa 62
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.213
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.049
IT - Italia 376
SE - Svezia 176
DE - Germania 110
GB - Regno Unito 84
IN - India 60
IE - Irlanda 55
CN - Cina 47
CH - Svizzera 27
FI - Finlandia 26
BG - Bulgaria 23
TG - Togo 23
JO - Giordania 17
NG - Nigeria 17
CI - Costa d'Avorio 16
FR - Francia 15
RU - Federazione Russa 14
HK - Hong Kong 7
BE - Belgio 6
UA - Ucraina 6
ES - Italia 5
HR - Croazia 5
IR - Iran 5
SG - Singapore 5
ZA - Sudafrica 5
AU - Australia 4
HN - Honduras 3
JP - Giappone 3
AT - Austria 2
CA - Canada 2
EE - Estonia 2
GR - Grecia 2
NL - Olanda 2
PL - Polonia 2
SA - Arabia Saudita 2
TR - Turchia 2
AL - Albania 1
EU - Europa 1
KG - Kirghizistan 1
MA - Marocco 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
Totale 2.213
Salva come PNG Salva come JPEG
Città #
Chandler 207
Ashburn 117
Bologna 77
Southend 66
Fairfield 60
Dublin 54
Princeton 48
Milan 35
New York 33
Wilmington 28
Helsinki 26
Lomé 23
Sofia 23
Woodbridge 22
Bern 21
Seattle 20
Berlin 19
Turin 19
Florence 18
Houston 18
Abeokuta 17
Amman 17
Abidjan 16
Beijing 16
Bremen 14
Boydton 12
Des Moines 12
Rome 12
Ann Arbor 11
Tappahannock 11
Washington 11
Cambridge 10
Redmond 10
San Diego 10
Hong Kong 7
Reggio Emilia 7
Los Angeles 6
Brussels 5
Cesena 5
Venezia 5
Westminster 5
Épalinges 5
Barcelona 4
Bhubaneswar 4
Bühl 4
Deiva Marina 4
Falls Church 4
Johannesburg 4
Mountain View 4
Noventa di Piave 4
Padova 4
Pune 4
Redwood City 4
Sala Bolognese 4
Dearborn 3
Ferrara 3
Hebei 3
Jinan 3
London 3
Mumbai 3
Mülheim 3
Napoli 3
Paris 3
Pianoro 3
Reggio Nell'emilia 3
Saint Petersburg 3
San Pedro Sula 3
Valeggio Sul Mincio 3
Verdellino 3
Acton 2
Alba 2
Albenga 2
Bari 2
Castel Guelfo di Bologna 2
Cercola 2
Changsha 2
Chicago 2
Cincinnati 2
City of Westminster 2
Colognola ai Colli 2
Desio 2
Falkenstein 2
Genoa 2
Haikou 2
Kilburn 2
Malnate 2
Medford 2
Melbourne 2
Miami 2
Montegaldella 2
Montesilvano Marina 2
Monza 2
Nanjing 2
Olalla 2
Parma 2
Porcia 2
Quartucciu 2
Rio Saliceto 2
Riyadh 2
Sassari 2
Totale 1.313
Salva come PNG Salva come JPEG
Nome #
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 139
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 119
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 117
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals 114
Multiplexed therapeutic drug monitoring (TDM) of antiviral drugs by LC–MS/MS 107
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 105
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 97
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 87
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction 86
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 83
Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections 75
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 74
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 70
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis 70
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 69
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis 69
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 67
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 65
Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring 64
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 64
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 63
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 57
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study 47
Reply to Baklouti et al., "Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?" 43
Suboptimal drug exposure leads selection of different subpopulations of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae in a critically ill patient 41
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 38
Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept 34
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 28
Validation of the INCREMENT-SOT-CPE score in a large cohort of liver transplant recipients with carbapenem-resistant Enterobacterales infection 27
Use of colistin in adult patients: A cross-sectional study 27
Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study 24
Prediction models for carbapenem-resistant Enterobacterales carriage at liver transplantation: A multicenter retrospective study 24
Successful and Safe Real-Time TDM-Guided Treatment of Invasive Pulmonary and Cerebral Aspergillosis Using Low-Dose Isavuconazole in a Patient with Primary Biliary Cirrhosis: Grand Round/A Case Study 22
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia 21
The impact of preservation fluid culture on graft site arteritis: a systematic review and metanalysis 16
Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients 16
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients? 15
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF) 14
Is acidemia at birth a risk factor for functional gastrointestinal disorders? 14
Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection: due to OXA-181-producing Klebsiella pneumoniae 9
Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration 8
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections? 7
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 7
Antimicrobial Resistance in Organ Transplant Recipients 6
Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections 5
Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections and/or Ventilator-Associated Pneumonia? 5
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia 4
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study) 3
Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study 3
Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysis 1
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria 1
Totale 2.371
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 2 0 4
2019/202081 8 2 0 3 9 10 12 11 10 5 2 9
2020/2021215 17 4 6 0 21 8 15 10 46 34 19 35
2021/2022552 19 18 15 49 32 25 18 63 31 87 112 83
2022/2023930 57 107 32 101 109 86 35 66 167 37 69 64
2023/2024577 71 61 56 72 71 99 38 28 41 40 0 0
Totale 2.371